VC

Vaibhav Chaturvedi

Active Director Director DIN 10498647
DIN 10498647 First appointment Feb 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaibhav Chaturvedi

Data last updated:

Vaibhav Chaturvedi is a Director at Wankrit Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10498647
Primary Designation Director
Industry Paper
First Appointment 08 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wankrit Pharma Private Limited U21000UP2024PTC197156
Director08 Feb 20242024Active

Board colleagues of Vaibhav Chaturvedi

NameDINCompanyDesignation
Prakriti Tripathi10498646Wankrit Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wankrit Pharma Private Limited
Premium access

Shareholding and investment profile for Vaibhav Chaturvedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaibhav Chaturvedi

Vaibhav Chaturvedi currently holds 1 directorship: Wankrit Pharma Private Limited (Director, since 08 Feb 2024).

Vaibhav Chaturvedi was first appointed on 08 Feb 2024 as Director at Wankrit Pharma Private Limited.

The current boards of Vaibhav Chaturvedi's companies include Prakriti Tripathi (Wankrit Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available